Robert J. Gould, Director at Epizyme, Inc. (EPZM), sold 32,108 shares at $18.01 ($578K) on 2015-12-29, disclosed to the SEC on 2015-12-31.
Scheduled sale ($578k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.01 | 20,303 | $366K | 63.2% |
| 2 | $18.02 | 11,805 | $213K | 36.8% |
| Total | $18.01 avg | 32,108 | $578K | 100% |
| Filing → |
| FULC | SELL | 2026-01-06 | $356K | — | Filing → |
| FULC | SELL | 2025-11-21 | $165K | — | Filing → |
| FULC | SELL | 2023-01-13 | $101K | — | Filing → |